Jason Wittes
Stock Analyst at Roth MKM
(3.77)
# 785
Out of 4,479 analysts
45
Total ratings
52.78%
Success rate
7.93%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DERM Journey Medical | Reinstates: Buy | $11 | $5.24 | +109.92% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $1.96 | +410.20% | 1 | Jun 26, 2024 | |
| LMAT LeMaitre Vascular | Reinstates: Buy | $100 | $81.19 | +23.17% | 1 | May 31, 2024 | |
| FBIO Fortress Biotech | Reiterates: Buy | $10 | $1.67 | +498.80% | 2 | May 16, 2024 | |
| OFIX Orthofix Medical | Upgrades: Buy | $15 → $20 | $13.29 | +50.49% | 3 | May 8, 2024 | |
| SYK Stryker | Maintains: Buy | $348 → $405 | $334.30 | +21.15% | 9 | May 1, 2024 | |
| IRMD IRadimed | Reinstates: Buy | $65 | $43.67 | +48.84% | 1 | Apr 22, 2024 | |
| STXS Stereotaxis | Reiterates: Buy | $5 | $1.76 | +184.09% | 4 | Mar 5, 2024 | |
| ARAY Accuray | Initiates: Buy | $9 | $1.75 | +414.29% | 2 | Feb 13, 2024 | |
| ENOV Enovis | Initiates: Buy | $75 | $44.71 | +67.75% | 2 | Oct 20, 2023 | |
| ATEC Alphatec Holdings | Initiates: Buy | $22 | $9.90 | +122.22% | 2 | Oct 20, 2023 | |
| ZBH Zimmer Biomet Holdings | Initiates: Neutral | $120 | $106.27 | +12.92% | 6 | Oct 20, 2023 | |
| GMED Globus Medical | Initiates: Buy | $75 | $68.05 | +10.21% | 2 | Oct 20, 2023 | |
| MASI Masimo | Initiates: Buy | $206 | $113.42 | +81.63% | 1 | Sep 14, 2022 | |
| DRI Darden Restaurants | Reinstates: Buy | $145 | $146.77 | -1.21% | 1 | Jun 27, 2022 | |
| BWAY BrainsWay | Initiates: Buy | $15 | $5.92 | +153.38% | 2 | Mar 3, 2022 | |
| NVCR NovoCure | Initiates: Buy | $200 | $16.80 | +1,090.48% | 3 | Feb 8, 2022 | |
| BTCY Biotricity | Initiates: Outperform | n/a | $0.76 | - | 1 | Jul 1, 2021 | |
| TGTX TG Therapeutics | Initiates: Buy | n/a | $18.31 | - | 1 | Feb 22, 2017 |
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $5.24
Upside: +109.92%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.96
Upside: +410.20%
LeMaitre Vascular
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $81.19
Upside: +23.17%
Fortress Biotech
May 16, 2024
Reiterates: Buy
Price Target: $10
Current: $1.67
Upside: +498.80%
Orthofix Medical
May 8, 2024
Upgrades: Buy
Price Target: $15 → $20
Current: $13.29
Upside: +50.49%
Stryker
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $334.30
Upside: +21.15%
IRadimed
Apr 22, 2024
Reinstates: Buy
Price Target: $65
Current: $43.67
Upside: +48.84%
Stereotaxis
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $1.76
Upside: +184.09%
Accuray
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.75
Upside: +414.29%
Enovis
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $44.71
Upside: +67.75%
Alphatec Holdings
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $9.90
Upside: +122.22%
Zimmer Biomet Holdings
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $106.27
Upside: +12.92%
Globus Medical
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $68.05
Upside: +10.21%
Masimo
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $113.42
Upside: +81.63%
Darden Restaurants
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $146.77
Upside: -1.21%
BrainsWay
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $5.92
Upside: +153.38%
NovoCure
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $16.80
Upside: +1,090.48%
Biotricity
Jul 1, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.76
Upside: -
TG Therapeutics
Feb 22, 2017
Initiates: Buy
Price Target: n/a
Current: $18.31
Upside: -